Weiss Asset Management LP Eli Lilly & CO Transaction History

Weiss Asset Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $94,233 - $118,175	-130 Reduced 30.37%	298 $269,000
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $253,461 - $339,095	428 New	428 $332,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $6.58 Million - $8.09 Million	-29,672 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $5.36 Million - $6.93 Million	29,672 New	29,672 $6.81 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $226,790 - $280,701	-1,905 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $55,598 - $68,863	-520 Reduced 21.44%	1,905 $250,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $258,965 - $281,688	2,425 New	2,425 $271,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.